ArkLaTex Fertility & Reproductive Located in Shreveport, Louisiana
About This Clinic
David T. Vandermolen, M.D., M.S. founded ArkLaTex Fertility and Reproductive Medicine to provide highest quality cost-effective fertility treatment, and it produced nationally recognized pregnancy success rates without sacrificing patient care.
Available Services & Features
Accessibility
- Wheelchair Accessible Entrance
- Wheelchair Accessible Parking
- Wheelchair Accessible Restroom
Amenities
- Restroom
Planning
- Recommends Appointment
📍 Location
2401 Greenwood Rd Suite A, Shreveport, LA 71103
Opening Hours
- Monday08:00 - 16:30
- Tuesday08:00 - 16:30
- Wednesday08:00 - 16:30
- Thursday08:00 - 16:30
- Friday08:00 - 16:30
- SaturdayClosed
- SundayClosed
IVF Success Rates (CDC Data)
These figures were reported to the U.S. Centers for Disease Control and Prevention (CDC) for 2022 by ArkLaTex Fertility and Reproductive Medicine, 2401 Greenwood Rd, Suite A, Shreveport, LA 71103 (medical director: David T. Vandermolen, MD). If this listing is a satellite office, its IVF cycles are usually reported under the main clinic.
The clinic reported 138 ART (IVF) cycles in 2022.
Live births per intended egg retrieval (patients using their own eggs)
| Patient age | Egg retrievals started | This clinic | US average* |
|---|---|---|---|
| Under 35 | 43 | 53.5% | 49.7% |
| 35–37 | 16 | Too few cycles | 36.3% |
| 38–40 | 17 | Too few cycles | 23.1% |
| Over 40 | 16 | Too few cycles | 7.7% |
This is the CDC's main measure: the percentage of intended egg retrievals that led to a live birth, counting all embryo transfers from that retrieval. *US average is the average across all reporting clinics, weighted by number of retrievals. Results depend heavily on age and diagnosis, so use them as a starting point and ask the clinic for its latest figures.
Services reported to the CDC
- ✅ Donor egg IVF
- ❌ Donated embryos
- ✅ Embryo freezing
- ✅ Egg freezing
- ✅ Gestational carrier (surrogacy)
- ✅ SART member
- ✅ Accredited embryology lab
Source: CDC, 2022 Final Assisted Reproductive Technology (ART) Summary (published December 2024).
